Nicholas T. Curtis
Known title: Chief Executive OfficerCIK: 0001230265
Associated companies
Transaction History
| LNSR | ▲ Buy | Grant | 130,662 | $0 | 6/3/2026 | View on chart |
| LNSR | ▼ Sell | Other | 0 | $0 | 5/6/2026 | View on chart |
| LNSR | ▼ Sell | Other | 0 | $0 | 2/18/2026 | View on chart |
| LNSR | ▼ Sell | Other | 0 | $0 | 1/11/2026 | View on chart |
| LNSR | ▲ Buy | Grant | 127,660 | $0 | 2/18/2025 | View on chart |
| LNSR | ▲ Buy | Grant | 71,400 | $0 | 5/6/2024 | View on chart |
| LNSR | ▲ Buy | Grant | 22,186 | $0 | 1/11/2023 | View on chart |
| LNSR | ▲ Buy | Grant | 30,000 | $0 | 1/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Lucid Capital Markets Begins Coverage of LENSAR, Sets $11 Target
Lucid Capital Markets has started coverage on LENSAR and issued a positive rating. The firm set a price target of $11, which sits near the upper end of the company’s 52‑week range. The new outlook may attract attention from investors looking at LENSAR’s valuation relative to its peers. The coverage adds a fresh perspective to the market’s view of the stock.
Lucid Capital Markets Begins Coverage of LENSAR, Sets $11 Target. Lucid Capital Markets has started coverage on LENSAR and issued a positive rating. The firm set a price target of $11, which sits near the upper end of the company’s 52‑week range. The new outlook may attract attention from investors looking at LENSAR’s valuation relative to its peers. The coverage adds a fresh perspective to the market’s view of the stock.